Samantha A. Jameson

Samantha A. Jameson is a patent litigation attorney with extensive experience handling both offensive and defensive patent disputes across various technology sectors. Her practice areas primarily involve life sciences technologies, including biotechnology, medical devices, and research tools, complemented by a strong background in computer peripherals, memory, video technology, and location services. While the tracked cases indicate plaintiff-side representation, her firm's overall practice and her individual profile reflect a balanced approach to patent enforcement and defense for operating companies.

Ms. Jameson is a Partner at Tensegrity Law Group, where she has practiced since 2013. Before joining Tensegrity, she served as a law clerk to the Honorable Richard Linn of the United States Court of Appeals for the Federal Circuit. Her practice extends to U.S. district courts, the International Trade Commission, and the Patent Trial and Appeal Board (PTAB), where she has served as lead IPR counsel.

She has been involved in significant patent litigation matters, notably representing 10x Genomics, Inc. In 10x Genomics, Inc. et al. v. Vizgen, Inc., she was counsel for the plaintiff, which resulted in a favorable global settlement for 10x Genomics, including the dismissal of Vizgen's counterclaims after summary judgment on antitrust counterclaims. She also served as counsel for 10x Genomics in a dispute against NanoString (later acquired by Bruker), where the firm secured a $31 million jury award, a permanent injunction, and a global settlement.

Ms. Jameson holds a J.D. from Duke University School of Law (2007), a Ph.D. in Cell Biology (2011) and an M.A. in Cell Biology (2007) from Duke University, and a B.A. in Biology from the University of Virginia (2002). She is admitted to practice in North Carolina (2007), California (2014), Virginia (2018), before the U.S. Patent and Trademark Office (2005), and the U.S. Court of Appeals for the Federal Circuit.